Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11912987 Methods for screening for cancer targets

Patent 11912987 was granted and assigned to KSQ Therapeutics on February, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

KSQ Therapeutics

0

Current Assignee

KSQ Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Micah Benson0

Date of Patent

February 27, 2024

0

Patent Application Number

173569880

Date Filed

June 24, 2021

0

Patent Citations

US Patent 8871445 CRISPR-Cas component systems, methods and compositions for sequence manipulation

0

US Patent 8889356 CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes

0

US Patent 8889418 Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation

0

US Patent 8895308 Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation

0

US Patent 8906616 Engineering of systems, methods and optimized guide compositions for sequence manipulation

0

US Patent 8906682 Methods for treatment of cancer

0

US Patent 8932814 CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes

0

US Patent 8945839 CRISPR-Cas systems and methods for altering expression of gene products

0

...

Patent Primary Examiner

Christian C Boesen

0

Patent abstract

This invention describes a novel CRISPR/Cas

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11912987 Methods for screening for cancer targets

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool